v3.26.1
Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Segment Revenue (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
BioBusiness Segment [Member]    
Schedule of Segment Revenue [Line Items]    
Revenue
Operating expenses:    
Research and development 901,144
General and administrative 1,378,074 364,368
Total operating expenses 2,279,218 364,368
Loss from operations (2,279,218) (364,368)
Other income (expense), net:    
Realized gain on sale of digital assets
Trading gains, net
Unrealized gain (loss) on digital assets
Change in FV of derivative
Change in FV of warrant liability
Interest income
Interest expense (2,222)
Foreign currency transaction loss
Total other income (expense), net (2,222)
Net loss (2,281,440) (364,368)
Digital Asset Segment [Member]    
Schedule of Segment Revenue [Line Items]    
Revenue
Operating expenses:    
Research and development
General and administrative 1,660,921
Total operating expenses 1,660,921  
Loss from operations (1,660,921)  
Other income (expense), net:    
Realized gain on sale of digital assets 15,100
Trading gains, net 2,029
Unrealized gain (loss) on digital assets (22,078,601)
Change in FV of derivative
Change in FV of warrant liability
Interest income
Interest expense
Foreign currency transaction loss (1,567)
Total other income (expense), net (22,063,039)
Net loss (23,723,960)
Corporate Segment [Member]    
Schedule of Segment Revenue [Line Items]    
Revenue
Operating expenses:    
Research and development
General and administrative 8,245,555
Total operating expenses 8,245,555  
Loss from operations (8,245,555)  
Other income (expense), net:    
Realized gain on sale of digital assets
Trading gains, net
Unrealized gain (loss) on digital assets
Change in FV of derivative 48,279
Change in FV of warrant liability
Interest income 7 3
Interest expense (857,183) (38,032)
Foreign currency transaction loss
Total other income (expense), net (808,897) (38,029)
Net loss (9,054,452) (38,029)
Consolidated [Member]    
Schedule of Segment Revenue [Line Items]    
Revenue
Operating expenses:    
Research and development 901,144
General and administrative 11,284,550 364,368
Total operating expenses 12,185,694 364,368
Loss from operations (12,185,694) (364,368)
Other income (expense), net:    
Realized gain on sale of digital assets 15,100
Trading gains, net 2,029
Unrealized gain (loss) on digital assets (22,078,601)
Change in FV of derivative 48,279
Change in FV of warrant liability
Interest income 7 3
Interest expense (859,405) (38,032)
Foreign currency transaction loss (1,567)
Total other income (expense), net (22,874,158) (38,029)
Net loss $ (35,059,852) $ (402,397)